Insiders Updates
Chief Commercial Officer BENEVICH ERIC sale 19,818 shares of Neurocrine Biosciences, Inc. [NBIX]
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Menu
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Neurocrine Biosciences, Inc.’s filing revealed that its Chief Commercial Officer BENEVICH ERIC unloaded Company’s shares for reported $2.64 million on
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Neurocrine Biosciences, Inc.’s recent filing unveils that its Chief Commercial Officer BENEVICH ERIC unloaded Company’s shares for reported $2.64 million
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Neurocrine Biosciences, Inc.’s recent filing unveils that its Chief Regulatory Officer Delaet Ingrid unloaded Company’s shares for reported $37346.0 on
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Neurocrine Biosciences, Inc.’s filing revealed that its Chief Regulatory Officer Delaet Ingrid unloaded Company’s shares for reported $37346.0 on Apr
Neurocrine Biosciences Inc. (NASDAQ:NBIX) does about 806.35K shares in volume on a normal day but saw 847325 shares change hands